Literature DB >> 9888514

Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells.

F Côté1, L Laflamme, M D Payet, N Gallo-Payet.   

Abstract

Nitric Oxide (NO) is a gas that diffuses freely through membranes of target cells to activate cGMP formation. NO is synthesised from arginine, by a family of Nitric Oxide Synthase (NOS). In the brain, NO influences synaptic plasticity, apoptosis and development. It has been recently shown that angiotensin II (Ang II) could mediate NO production by its two types of receptors, AT1 and AT2. Since we have shown that Ang II, via the AT2 receptor could induce neurite outgrowth and morphological differentiation of NG108-15 cells, the aim of the study was to investigate if NO could be one of the second messengers involved in the Ang II effect. Using the Griess colorimetric assay, we found that Ang II, by its AT2 receptor, induced nitrite formation from NO. This effect was abolished by the N-nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor. We also found that treatment of the cells with S-nitroso-N-acetylpenicillamine (SNAP), an exogenous source of NO, induced the same morphological differentiation. These results demonstrate that the morphological differentiation induced by the AT2 receptor is partly due to an increase in NO production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888514     DOI: 10.3109/07435809809032622

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  13 in total

1.  Nitric oxide is an essential negative regulator of cell proliferation in Xenopus brain.

Authors:  N Peunova; V Scheinker; H Cline; G Enikolopov
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

2.  Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II.

Authors:  I Idris; N Tyreman; S Gray; R Donnelly
Journal:  Diabetologia       Date:  2002-02       Impact factor: 10.122

Review 3.  Regulation of neuronal proliferation and differentiation by nitric oxide.

Authors:  Sarah M Gibbs
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 4.  Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.

Authors:  Masatsugu Horiuchi; Masaki Mogi
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.

Authors:  Gali Umschweif; Sigal Liraz-Zaltsman; Dalia Shabashov; Alexander Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

6.  Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats.

Authors:  Juan Gao; Hao Zhang; Khang D Le; Jie Chao; Lie Gao
Journal:  Am J Hypertens       Date:  2011-03-10       Impact factor: 2.689

7.  Preincubation with atrial natriuretic peptide protects NG108-15 cells against the toxic/proapoptotic effects of the nitric oxide donor S-nitroso- N-acetylpenicillamine.

Authors:  Siew Boon Cheng Chew; Pui Ying Leung; Ronald Ray Fiscus
Journal:  Histochem Cell Biol       Date:  2003-08-14       Impact factor: 4.304

8.  Nitric oxide negatively regulates mammalian adult neurogenesis.

Authors:  Michael A Packer; Yuri Stasiv; Abdellatif Benraiss; Eva Chmielnicki; Alexander Grinberg; Heiner Westphal; Steven A Goldman; Grigori Enikolopov
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

9.  How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-19       Impact factor: 5.555

10.  Roles of Brain Angiotensin II in Cognitive Function and Dementia.

Authors:  Masaki Mogi; Jun Iwanami; Masatsugu Horiuchi
Journal:  Int J Hypertens       Date:  2012-12-11       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.